Edwards Lifesciences Corporation Cash and Cash Equivalents, Fair Value Disclosure
Edwards Lifesciences Corporation (EW) had Cash and Cash Equivalents, Fair Value Disclosure of $2.28 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-04
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $2.28B.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $1.97B.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $2.39B.
- 2024-12-31: Cash and Cash Equivalents, Fair Value Disclosure $2.38B.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $2.28B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.97B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.39B 10-Q · filed 2026-08-04 |
| 2024-12-31 | $2.38B 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |